How Leukemia Inhibitory Factor Affects Muscle Cell Development
Author Information
Author(s): Liam C Hunt, Aradhana Upadhyay, Jalal A Jazayeri, Elizabeth M Tudor, Jason D White
Primary Institution: University of Melbourne
Hypothesis
Does leukemia inhibitory factor (LIF) inhibit myogenic differentiation through caspase-3 activation?
Conclusion
The study shows that LIF inhibits myogenic differentiation by regulating caspase-3 activation and other myogenic factors.
Supporting Evidence
- LIF treatment decreased the percentage of cells positive for active caspase-3 during differentiation.
- Caspase-3 activity was significantly reduced with LIF treatment.
- LIF inhibited the expression of myogenic regulatory factors myoD and myogenin.
- LIF treatment maintained myoblasts in a proliferative state longer than controls.
Takeaway
Leukemia inhibitory factor (LIF) slows down the process of muscle cell development by affecting certain proteins, which can lead to less muscle growth.
Methodology
C2C12 myoblasts were treated with LIF and assessed for differentiation markers and caspase-3 activity over time.
Limitations
The study primarily focuses on in vitro conditions and may not fully represent in vivo muscle regeneration processes.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website